T. Rowe Price Associates’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136M Buy
2,606,778
+1,220,473
+88% +$60M 0.01% 612
2026
Q1
$65.4M Buy
1,386,305
+384,367
+38% +$19.1M 0.01% 709
2025
Q4
$47.2M Buy
1,001,938
+2,820
+0.3% +$131K 0.01% 831
2025
Q3
$42M Buy
999,118
+14,695
+1% +$591K ﹤0.01% 857
2025
Q2
$36.2M Buy
984,423
+869,024
+753% +$28.9M ﹤0.01% 818
2025
Q1
$3.5M Buy
115,399
+13,635
+13% +$393K ﹤0.01% 1369
2024
Q4
$2.89M Buy
101,764
+55,651
+121% +$1.5M ﹤0.01% 1472
2024
Q3
$1.2M Buy
46,113
+25,421
+123% +$495K ﹤0.01% 1894
2024
Q2
$0 Buy
+20,692
New +$292K ﹤0.01% 3040

Other funds holding AHR

T. Rowe Price Associates's AHR Position: Q2 2026 in Review

T. Rowe Price Associates increased its American Healthcare REIT (AHR) stake by 88% in Q2 2026, buying an estimated $60M and bringing the position to 2,606,778 shares worth $136M. The position accounts for 0.01% of the portfolio, ranked #612.

T. Rowe Price Associates first reported a position in AHR in Q2 2024 and has held it in 9 quarters since. 572 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • T. Rowe Price Associates held 2,606,778 shares of American Healthcare REIT worth $136M as of Q2 2026.
  • T. Rowe Price Associates bought 1,220,473 American Healthcare REIT shares in Q2 2026, an estimated $60M.
  • American Healthcare REIT made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #612 holding.
  • T. Rowe Price Associates first reported a position in American Healthcare REIT in Q2 2024 and has held it in 9 quarters since.
  • 572 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.